Objectives | Primary Focus | Baptist Health South Florida
Skip Ribbon Commands Skip to main content
 
2018
Primary Care Focus Symposium
17th Annual
Friday-Sunday, June 29-July 1, 2018
Ocean Reef Club, Key Largo, Florida
Register

2017 Objectives 

Friday, June 30 
Sexually Transmitted Infections and Living with HIV as a Chronic Disease
Upon completion of this presentation, participants should be better able to:
  • Recognize the most common sexually transmitted infections, explain their symptoms and examine the significant role of antibiotic resistance.
  • Examine the implications of non-AIDS-related morbidity in chronic HIV infection.
Hormone Replacement Therapy: Today! Not Yesterday!
Upon completion of this presentation, participants should be better able to:
  • Examine the data supporting the use of hormone replacement therapy, and analyze where the negative consumer reaction and clinical bias associated with its use transpired.
  • Recognize the rationale behind bio-identical hormone therapy and how it differs from therapies offered in the past.
Facts Vs. Fiction Surrounding Medical Marijuana: A Traditional Medicine’s Modern Perspectives
Upon completion of this presentation, participants should be better able to:
  • Discuss medical-legal ethics compared with bioethical considerations with respect to rendering compassionate care while under federal prohibition.
  • Analyze the potential impact of Florida’s Amendment 2’s mandate and its federal implications to medical practice.
  • Describe the significance of ethnobotanical and cultural uses of cannabis.
  • Identify the endocannabinoid receptor system ligands’ unique mechanisms of action, and their essential roles in modulating physiology.
  • Assess the clinical indications for cannabis as a potential therapy for specific healthcare diagnoses supported by the current evidence for efficacy.
Comprehensive Weight Management: Exploring a Modern Treatment Paradigm for Obesity
Upon completion of this symposium, participants should be better able to:
  • Examine current best practices for assessment and lifestyle management of obesity.
  • Demonstrate how obesity is associated with a significant increase in mortality and with risk of many disorders, including diabetes mellitus, hypertension, dyslipidemia, heart disease, stroke, sleep apnea, cancer and others.
Food Psychology: Why We Eat More Than We Think
Upon completion of this presentation, participants should be better able to:
  • Recognize how most people are not mindful of their total daily food consumption.
  • List environmental factors that lead to overeating.
  • Explain helpful techniques that assist individuals track their food consumption and as a result reduce weight. 
  • Examine common pitfalls that cause individuals to become overeaters.​
Saturday, July 1
Cancer Module 
An Overview of Pancreatic Cancer
Upon completion of this presentation, participants should be better able to:
  • Recognize the clinical presentations associated with pancreatic cancer in order to differentiate the diagnosis.
  • Describe diagnostic studies that are important to the workup for diagnosing pancreatic cancer.
  • Explain the medical and surgical treatments available and examine the potential complications that are associated with pancreatic cancer. 
Minimally Invasive Laparoscopic and  Robotic Surgery in Gynecologic Oncology
Upon completion of this presentation, participants should be better able to:
  • Analyze the epidemiology for the human papilloma virus, describe current vaccines available and implement appropriate treatment strategies.
  • Assess the risk factors associated with abnormal bleeding in females and determine when a referral to a specialist is necessary.
  • Examine the metabolic syndrome and its gynecologic consequences that may be linked with certain gynecologic cancers.
Multiple Myeloma
Upon completion of this presentation, participants should be better able to:
  • Examine the current clinical assessment of a potential patient with multiple myeloma in order to verify the diagnosis and improve patient outcome.
  • Explain contemporary management in the treatment of multiple myeloma and describe novel therapeutic options available. 
Genitourinary Malignancies
Upon completion of this presentation, participants should be better able to:
  • Recognize genitourinary cancers and evaluate the evidence for screening and the role of PSA testing.
  • Explain how to appropriately manage hematuria and frontline imaging.
  • Recognize appropriate therapies and applicable post therapy follow-up for genitourinary malignancies.
  • Evaluate potential pitfalls associated with post-cystectomy testing.

Targeted Therapies: New Treatment for Common Malignancies: Special Focus on Breast Cancer
Upon completion of this presentation, participants should be better able to:

  • Examine targeted therapy for estrogen receptor positive patients and explain appropriate treatment strategies.
  • Provide evidence-based radiologic surveillance treatment as an option for high-risk patients.
  • Identify patients who are candidates for chemoprevention and genetic testing.
  • Determine which high-risk patients may benefit from prophylactic surgery.


Sunday, July 2
Inflammatory Bowel Disease
Upon completion of this presentation, participants should be better able to:
  • Distinguish between the signs, symptoms and complications of ulcerative colitis and Crohn’s disease.
  • Accurately assess the severity and disease activity of ulcerative colitis and Crohn’s disease.
  • Explain the use of drug therapies for ulcerative colitis and Crohn’s disease on the basis of risk-benefit.
Psoriasis: An Update
Upon completion of this presentation, participants should be better able to:
  • Examine epidemiologic factors, clinical presentations and comorbidities associated with psoriasis.
  • Recognize current treatments available, including conventional and biologic therapies, and determine when to refer a patient with psoriasis to a specialist.
Hepatitis C: Then and Now
Upon completion of this presentation, participants should be better able to:
  • Recognize the long-term morbidity and mortality associated with chronic hepatitis C infection.
  • Monitor patients for antiviral therapy response and toxicities.


DISCLAIMER

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult FDA-approved uses and information prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying any information provided for any professional use.

​​​​​​